Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia
- 31 August 2007
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 197 (2), 211.e1-211.e4
- https://doi.org/10.1016/j.ajog.2007.05.022
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studiesBMJ, 2005
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Prospective Analysis of Placenta Growth Factor (PlGF) Concentrations in the Plasma of Women with Normal Pregnancy and Pregnancies Complicated by PreeclampsiaHypertension in Pregnancy, 2004
- Summary of the NHLBI Working Group on Research on Hypertension During PregnancyHypertension, 2003
- Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaJCI Insight, 2003
- Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2001
- Risk Factors for Preeclampsia, Abruptio Placentae, and Adverse Neonatal Outcomes among Women with Chronic HypertensionNew England Journal of Medicine, 1998
- Low-Dose Aspirin to Prevent Preeclampsia in Women at High RiskNew England Journal of Medicine, 1998
- Trial of Calcium to Prevent PreeclampsiaNew England Journal of Medicine, 1997
- Prevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant WomenNew England Journal of Medicine, 1993